Cancer high-risk subjects identified by serum pepsinogen tests: Outcomes after 10-year follow-up in asymptomatic middle-aged males

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 838-845

  Yanaoka, Kimihiko ^a   Oka, Masashi ^a   Mukoubayashi, Chizu ^a   Yoshimura, Noriko ^c   Enomoto, Shotaro ^a   Iguchi, Mikitaka ^a   Magari, Hirohito ^a   Utsunomiya, Hirotoshi ^a   Tamai, Hideyuki ^a   Arii, Kenji ^a   Ohata, Hiroshi ^b   Fujishiro, Mitsuhiro ^c   Takeshita, Tatsuya ^a   Mohara, Osamu ^b   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Wakayama Wellness Foundation   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE DURATION; FOLLOW UP; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ATROPHY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PEPSINOGEN A; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149127623     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2762     Document Type: Article

References (44)

1. Axon A. Gastric cancer and Helicobacter pylori. Aliment Pharmacol Ther 2002;16:83-8.
2. Parkin DM. International variation. Oncogene 2004;23:6329-40.
3. Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol 2002;12:111-27.
4. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003;39:1603-9.
5. Ministry of Health, Labour and Welfare. Vital statistics of Japan, statistics and information. Vol. 3. Tokyo: Minister's Secretariat, Ministry of Health, Labour and Welfare; 2005. p. 138-9.
6. Hisamichi S. Screening for gastric cancer. World J Surg 1989;13:31-7.
7. Kawai K. Screening for gastric cancer in Japan. Clin Gastroenterol 1978;7:605-22.
8. Annual report on gastrointestinal mass survey [in Japanese]. In: Statistic Committee of Japanese Association of Gastrointestinal Mass Survey; 2004. p. 196-207.
9. Oshima A, Hanai A, Fujimoto I. Evaluation of a mass screening program for stomach cancer. Natl Cancer Inst Monogr 1979;53:181-6.
10. Hisamichi S, Sugahara N. Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol 1984;11:211-33.
11. Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986;38:829-33.
12. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takano A. The evaluation of screening for gastric cancer in Miyagi prefecture, Japan: a population-based case-control study. Int J Cancer 1995;60:45-8.
13. Abe Y, Mitsushima T, Nagatani K, Ikuma H, Nanbara Y. Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study [in Japanese]. Jpn J Gastroenterol 1995;92:836-45.
14. Nishizawa M. Present status and prospect for cancer screening [in Japanese]. J Gastroenterol Mass Surv1993;78:100-3.
15. Fukao A, Hisamichi S, Komatsu S, Sugahara N, Takano A. Risk of leukemia among participants of gastric cancer mass screening survey in Japan: a population-based, case-control study. Cancer Detect Prev 1992;16:283-6.
16. Sakka M, Hisamichi S, Takano A, Hashizume T, Sasano N, Uzuka Y. Mass survey of gastric cancer and leukemia in Miyagi Prefecture, Japan. Tohoku J Exp Med 1982;138:239-43.
17. Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-4.
18. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086-90.
19. Ichinose M, Yahagi N, Oka M, et al. Screening for gastric cancer in Japan. In: Wu GY, Aziz K, editors. Cancer screening. Totowa (NJ): Humana Press; 2001. p. 255-68.
20. Correa P. Human gastric carcinogenesis: a multi-step and multifactorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
21. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosa histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
22. Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
23. Kodoi K, Yoshihara M, Sumii K, Haruma K, Kajiyama G. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995;30:452-60.
24. Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res 1995;86:1210-5.
25. Yoshihara M, Sumii K, Haruma K, et al. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Hiroshima J Med Sci 1997;46:81-6.
26. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693-7.
27. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735-9.
28. Ohata H, Oka M, Yanaoka K, et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005;96:713-20.
29. Ichinose M, Miki K, Furihata C, et al. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126:183-91.
30. Watanabe Y, Kurata JH, Mizuno S, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-7.
31. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993;4:297-305.
32. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993;4:307-12.
33. Sasajima M, Ohtsuka T, Hishina R, Urita Y, Miki K. Serum pepsinogen in gastric cancer screening [in Japanese]. J Jpn Soc Intern Med 2005;94:37-42.
34. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
35. Stemmermann GN, Samloff IM, Nomura AM, Heilbrun LK. Serum pepsinogens I and II and stomach cancer. Clin Chim Acta 1987;163:191-8.
36. Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1993;2:461-6.
37. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141-7.
38. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982;50:2554-65.
39. Lauren P. Histogenesis of intestinal and diffuse types of gastric carcinoma. Scand J Gastroenterol 1991;26:160-4.
40. Nardone G, Rocco A, Malfertheiner P. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-70.
41. Plebani M, Basso D, Cassro M, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
42. Mardh E, Mardh S, Mardh B, Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002;320:17-27.
43. Fukao A, Chisato H, Shibuya D, et al. Committee for the development of gastric cancer screening (Clinical edition). Gastric cancer screening guidelines based on evaluation of efficacy. Jpn J Cancer Chemother 2006;33:1183-97.
44. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Moreira-Dias L. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2007;22:1594-604.